134 related articles for article (PubMed ID: 12587244)
1. The molecular biology of laryngeal cancer.
Ha PK; Califano JA
Otolaryngol Clin North Am; 2002 Oct; 35(5):993-1012. PubMed ID: 12587244
[TBL] [Abstract][Full Text] [Related]
2. Tumour suppressor genes and head and neck cancer.
Jones AS
Adv Otorhinolaryngol; 2000; 56():249-60. PubMed ID: 10868242
[No Abstract] [Full Text] [Related]
3. A causal role for human papillomavirus in head and neck cancer.
Gillison ML; Lowy DR
Lancet; 2004 May; 363(9420):1488-9. PubMed ID: 15135592
[No Abstract] [Full Text] [Related]
4. Two sites of head and neck squamous cell carcinoma: utility of loss of heterozygosity.
Sharma A; Wayne S; Nikiforova MN; Johnson JT; Walvekar RR
Ann Otol Rhinol Laryngol; 2008 Aug; 117(8):591-3. PubMed ID: 18771075
[TBL] [Abstract][Full Text] [Related]
5. Association between UGT1A1 Polymorphism and Risk of Laryngeal Squamous Cell Carcinoma.
Huangfu H; Pan H; Wang B; Wen S; Han R; Li L
Int J Environ Res Public Health; 2016 Jan; 13(1):. PubMed ID: 26751466
[TBL] [Abstract][Full Text] [Related]
6. [Genomic characterization of head and neck squamous cell carcinoma: Impact and challenges for therapeutic management].
Saada-Bouzid E; Milano G; Thariat J
Bull Cancer; 2018 Sep; 105(9):820-829. PubMed ID: 29937334
[TBL] [Abstract][Full Text] [Related]
7. [Loss of heterozygosity analysis in the regions harboring anticancer tumor suppressor genes in laryngeal cancer].
Kiwerska K
Otolaryngol Pol; 2010; 64(1):55-6. PubMed ID: 20476595
[No Abstract] [Full Text] [Related]
8. HPV-associated p16 INK4A expression and response to therapy and survival in selected head and neck cancers.
Kanyilmaz G; Ekinci O; Muge A; Celik S; Ozturk F
Asian Pac J Cancer Prev; 2015; 16(1):253-8. PubMed ID: 25640361
[TBL] [Abstract][Full Text] [Related]
9. An absence of founder BRCA2 mutations in individuals with squamous cell carcinoma of the head and neck.
Hamel N; Manning A; Black MJ; Tonin PN; Foulkes WD
Int J Cancer; 1999 Dec; 83(6):803-4. PubMed ID: 10597198
[No Abstract] [Full Text] [Related]
10. Pediatric laryngeal carcinoma in a heterozygous carrier of Fanconi anemia.
D'Souza AM; Mark J; Demarcantonio M; Leino D; Sisson R; Geller JI
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28139070
[TBL] [Abstract][Full Text] [Related]
11. [Basics of tumor development and importance of human papilloma virus (HPV) for head and neck cancer].
Wittekindt C; Wagner S; Mayer CS; Klußmann JP
Laryngorhinootologie; 2012 Mar; 91 Suppl 1():S1-26. PubMed ID: 22456913
[TBL] [Abstract][Full Text] [Related]
12. Definition of a tumor suppressor gene locus on the short arm of chromosome 3 in squamous cell carcinoma of the head and neck by means of microsatellite markers.
Rowley H; Jones A; Spandidos D; Field J
Arch Otolaryngol Head Neck Surg; 1996 May; 122(5):497-501. PubMed ID: 8615966
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity at 8p, 9p and 17q in laryngeal cytological specimens.
Rizos E; Sourvinos G; Spandidos DA
Oral Oncol; 1998 Nov; 34(6):519-23. PubMed ID: 9930365
[TBL] [Abstract][Full Text] [Related]
14. p53 codon 72 polymorphism and its overexpression in patients with laryngeal carcinoma: Prognostic implications.
Kalsotra G; Gupta AK; Gupta R; Rathi R; Prasad R
Ear Nose Throat J; 2016 Jun; 95(6):E5-E11. PubMed ID: 27304453
[TBL] [Abstract][Full Text] [Related]
15. [Loss of heterozygosity on chromosome 9p13-23 in microdissected laryngeal squamous cell carcinoma by microsatellite analysis].
Xu X; An Q; Zhang J; Tang P; Cheng S
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 36(5):367-71. PubMed ID: 12761947
[TBL] [Abstract][Full Text] [Related]
16. Applying the molecular biology and epigenetics of head and neck cancer in everyday clinical practice.
Glazer CA; Chang SS; Ha PK; Califano JA
Oral Oncol; 2009; 45(4-5):440-6. PubMed ID: 18674958
[TBL] [Abstract][Full Text] [Related]
17. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
[TBL] [Abstract][Full Text] [Related]
18. Molecular markers in laryngeal squamous cell carcinoma: towards an integrated clinicobiological approach.
Almadori G; Bussu F; Cadoni G; Galli J; Paludetti G; Maurizi M
Eur J Cancer; 2005 Mar; 41(5):683-93. PubMed ID: 15763643
[TBL] [Abstract][Full Text] [Related]
19. [Association between genetic polymorphism in DNA repair genes XRCC3 and risks of laryngeal and hypopharyngeal carcinomas].
Wen SX; Zhang XM; Tang PZ; Zhao D; Guo YL; Tan W; Lin DX
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Nov; 42(11):856-9. PubMed ID: 18300452
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus infection and cyclin D1 gene amplification in laryngeal squamous cell carcinoma: biologic function and clinical significance.
Almadori G; Galli J; Cadoni G; Bussu F; Maurizi M
Head Neck; 2002 Jun; 24(6):597-604. PubMed ID: 12112558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
